The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions

There is increasing evidence that frontotemporal dementia and amyotrophic lateral sclerosis are part of a disease continuum. Recently, a hexanucleotide repeat expansion in C9orf72 was identified as a major cause of both sporadic and familial frontotemporal dementia and amyotrophic lateral sclerosis....

Full description

Saved in:
Bibliographic Details
Published inBrain (London, England : 1878) Vol. 135; no. 3; pp. 723 - 735
Main Authors Simón-Sánchez, Javier, Dopper, Elise G. P., Cohn-Hokke, Petra E., Hukema, Renate K., Nicolaou, Nayia, Seelaar, Harro, de Graaf, J. Roos A., de Koning, Inge, van Schoor, Natasja M., Deeg, Dorly J. H., Smits, Marion, Raaphorst, Joost, van den Berg, Leonard H., Schelhaas, Helenius J., De Die-Smulders, Christine E. M., Majoor-Krakauer, Danielle, Rozemuller, Annemieke J. M., Willemsen, Rob, Pijnenburg, Yolande A. L., Heutink, Peter, van Swieten, John C.
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.03.2012
Subjects
Online AccessGet full text
ISSN0006-8950
1460-2156
1460-2156
DOI10.1093/brain/awr353

Cover

Abstract There is increasing evidence that frontotemporal dementia and amyotrophic lateral sclerosis are part of a disease continuum. Recently, a hexanucleotide repeat expansion in C9orf72 was identified as a major cause of both sporadic and familial frontotemporal dementia and amyotrophic lateral sclerosis. The aim of this study was to investigate clinical and neuropathological characteristics of hexanucleotide repeat expansions in C9orf72 in a large cohort of Dutch patients with frontotemporal dementia. Repeat expansions were successfully determined in a cohort of 353 patients with sporadic or familial frontotemporal dementia with or without amyotrophic lateral sclerosis, and 522 neurologically normal controls. Immunohistochemistry was performed in a series of 10 brains from patients carrying expanded repeats using a panel of antibodies. In addition, the presence of RNA containing GGGGCC repeats in paraffin-embedded sections of post-mortem brain tissue was investigated using fluorescence in situ hybridization with a locked nucleic acid probe targeting the GGGGCC repeat. Hexanucleotide repeat expansions in C9orf72 were found in 37 patients with familial (28.7%) and five with sporadic frontotemporal dementia (2.2%). The mean age at onset was 56.9 ± 8.3 years (range 39-76), and disease duration 7.6 ± 4.6 years (range 1-22). The clinical phenotype of these patients varied between the behavioural variant of frontotemporal dementia (n = 34) and primary progressive aphasia (n = 8), with concomitant amyotrophic lateral sclerosis in seven patients. Predominant temporal atrophy on neuroimaging was present in 13 of 32 patients. Pathological examination of the 10 brains from patients carrying expanded repeats revealed frontotemporal lobar degeneration with neuronal transactive response DNA binding protein-positive inclusions of variable type, size and morphology in all brains. Fluorescence in situ hybridization analysis of brain material from patients with the repeat expansion, a microtubule-associated protein tau or a progranulin mutation, and controls did not show RNA-positive inclusions specific for brains with the GGGGCC repeat expansion. The hexanucleotide repeat expansion in C9orf72 is an important cause of frontotemporal dementia with and without amyotrophic lateral sclerosis, and is sometimes associated with primary progressive aphasia. Neuropathological hallmarks include neuronal and glial inclusions, and dystrophic neurites containing transactive response DNA binding protein. Future studies are needed to explain the wide variation in clinical presentation.
AbstractList There is increasing evidence that frontotemporal dementia and amyotrophic lateral sclerosis are part of a disease continuum. Recently, a hexanucleotide repeat expansion in C9orf72 was identified as a major cause of both sporadic and familial frontotemporal dementia and amyotrophic lateral sclerosis. The aim of this study was to investigate clinical and neuropathological characteristics of hexanucleotide repeat expansions in C9orf72 in a large cohort of Dutch patients with frontotemporal dementia. Repeat expansions were successfully determined in a cohort of 353 patients with sporadic or familial frontotemporal dementia with or without amyotrophic lateral sclerosis, and 522 neurologically normal controls. Immunohistochemistry was performed in a series of 10 brains from patients carrying expanded repeats using a panel of antibodies. In addition, the presence of RNA containing GGGGCC repeats in paraffin-embedded sections of post-mortem brain tissue was investigated using fluorescence in situ hybridization with a locked nucleic acid probe targeting the GGGGCC repeat. Hexanucleotide repeat expansions in C9orf72 were found in 37 patients with familial (28.7%) and five with sporadic frontotemporal dementia (2.2%). The mean age at onset was 56.9 plus or minus 8.3 years (range 39-76), and disease duration 7.6 plus or minus 4.6 years (range 1-22). The clinical phenotype of these patients varied between the behavioural variant of frontotemporal dementia (n = 34) and primary progressive aphasia (n = 8), with concomitant amyotrophic lateral sclerosis in seven patients. Predominant temporal atrophy on neuroimaging was present in 13 of 32 patients. Pathological examination of the 10 brains from patients carrying expanded repeats revealed frontotemporal lobar degeneration with neuronal transactive response DNA binding protein-positive inclusions of variable type, size and morphology in all brains. Fluorescence in situ hybridization analysis of brain material from patients with the repeat expansion, a microtubule-associated protein tau or a progranulin mutation, and controls did not show RNA-positive inclusions specific for brains with the GGGGCC repeat expansion. The hexanucleotide repeat expansion in C9orf72 is an important cause of frontotemporal dementia with and without amyotrophic lateral sclerosis, and is sometimes associated with primary progressive aphasia. Neuropathological hallmarks include neuronal and glial inclusions, and dystrophic neurites containing transactive response DNA binding protein. Future studies are needed to explain the wide variation in clinical presentation.
There is increasing evidence that frontotemporal dementia and amyotrophic lateral sclerosis are part of a disease continuum. Recently, a hexanucleotide repeat expansion in C9orf72 was identified as a major cause of both sporadic and familial frontotemporal dementia and amyotrophic lateral sclerosis. The aim of this study was to investigate clinical and neuropathological characteristics of hexanucleotide repeat expansions in C9orf72 in a large cohort of Dutch patients with frontotemporal dementia. Repeat expansions were successfully determined in a cohort of 353 patients with sporadic or familial frontotemporal dementia with or without amyotrophic lateral sclerosis, and 522 neurologically normal controls. Immunohistochemistry was performed in a series of 10 brains from patients carrying expanded repeats using a panel of antibodies. In addition, the presence of RNA containing GGGGCC repeats in paraffin-embedded sections of post-mortem brain tissue was investigated using fluorescence in situ hybridization with a locked nucleic acid probe targeting the GGGGCC repeat. Hexanucleotide repeat expansions in C9orf72 were found in 37 patients with familial (28.7%) and five with sporadic frontotemporal dementia (2.2%). The mean age at onset was 56.9 ± 8.3 years (range 39-76), and disease duration 7.6 ± 4.6 years (range 1-22). The clinical phenotype of these patients varied between the behavioural variant of frontotemporal dementia (n = 34) and primary progressive aphasia (n = 8), with concomitant amyotrophic lateral sclerosis in seven patients. Predominant temporal atrophy on neuroimaging was present in 13 of 32 patients. Pathological examination of the 10 brains from patients carrying expanded repeats revealed frontotemporal lobar degeneration with neuronal transactive response DNA binding protein-positive inclusions of variable type, size and morphology in all brains. Fluorescence in situ hybridization analysis of brain material from patients with the repeat expansion, a microtubule-associated protein tau or a progranulin mutation, and controls did not show RNA-positive inclusions specific for brains with the GGGGCC repeat expansion. The hexanucleotide repeat expansion in C9orf72 is an important cause of frontotemporal dementia with and without amyotrophic lateral sclerosis, and is sometimes associated with primary progressive aphasia. Neuropathological hallmarks include neuronal and glial inclusions, and dystrophic neurites containing transactive response DNA binding protein. Future studies are needed to explain the wide variation in clinical presentation.
There is increasing evidence that frontotemporal dementia and amyotrophic lateral sclerosis are part of a disease continuum. Recently, a hexanucleotide repeat expansion in C9orf72 was identified as a major cause of both sporadic and familial frontotemporal dementia and amyotrophic lateral sclerosis. The aim of this study was to investigate clinical and neuropathological characteristics of hexanucleotide repeat expansions in C9orf72 in a large cohort of Dutch patients with frontotemporal dementia. Repeat expansions were successfully determined in a cohort of 353 patients with sporadic or familial frontotemporal dementia with or without amyotrophic lateral sclerosis, and 522 neurologically normal controls. Immunohistochemistry was performed in a series of 10 brains from patients carrying expanded repeats using a panel of antibodies. In addition, the presence of RNA containing GGGGCC repeats in paraffin-embedded sections of post-mortem brain tissue was investigated using fluorescence in situ hybridization with a locked nucleic acid probe targeting the GGGGCC repeat. Hexanucleotide repeat expansions in C9orf72 were found in 37 patients with familial (28.7%) and five with sporadic frontotemporal dementia (2.2%). The mean age at onset was 56.9 ± 8.3 years (range 39-76), and disease duration 7.6 ± 4.6 years (range 1-22). The clinical phenotype of these patients varied between the behavioural variant of frontotemporal dementia (n = 34) and primary progressive aphasia (n = 8), with concomitant amyotrophic lateral sclerosis in seven patients. Predominant temporal atrophy on neuroimaging was present in 13 of 32 patients. Pathological examination of the 10 brains from patients carrying expanded repeats revealed frontotemporal lobar degeneration with neuronal transactive response DNA binding protein-positive inclusions of variable type, size and morphology in all brains. Fluorescence in situ hybridization analysis of brain material from patients with the repeat expansion, a microtubule-associated protein tau or a progranulin mutation, and controls did not show RNA-positive inclusions specific for brains with the GGGGCC repeat expansion. The hexanucleotide repeat expansion in C9orf72 is an important cause of frontotemporal dementia with and without amyotrophic lateral sclerosis, and is sometimes associated with primary progressive aphasia. Neuropathological hallmarks include neuronal and glial inclusions, and dystrophic neurites containing transactive response DNA binding protein. Future studies are needed to explain the wide variation in clinical presentation.There is increasing evidence that frontotemporal dementia and amyotrophic lateral sclerosis are part of a disease continuum. Recently, a hexanucleotide repeat expansion in C9orf72 was identified as a major cause of both sporadic and familial frontotemporal dementia and amyotrophic lateral sclerosis. The aim of this study was to investigate clinical and neuropathological characteristics of hexanucleotide repeat expansions in C9orf72 in a large cohort of Dutch patients with frontotemporal dementia. Repeat expansions were successfully determined in a cohort of 353 patients with sporadic or familial frontotemporal dementia with or without amyotrophic lateral sclerosis, and 522 neurologically normal controls. Immunohistochemistry was performed in a series of 10 brains from patients carrying expanded repeats using a panel of antibodies. In addition, the presence of RNA containing GGGGCC repeats in paraffin-embedded sections of post-mortem brain tissue was investigated using fluorescence in situ hybridization with a locked nucleic acid probe targeting the GGGGCC repeat. Hexanucleotide repeat expansions in C9orf72 were found in 37 patients with familial (28.7%) and five with sporadic frontotemporal dementia (2.2%). The mean age at onset was 56.9 ± 8.3 years (range 39-76), and disease duration 7.6 ± 4.6 years (range 1-22). The clinical phenotype of these patients varied between the behavioural variant of frontotemporal dementia (n = 34) and primary progressive aphasia (n = 8), with concomitant amyotrophic lateral sclerosis in seven patients. Predominant temporal atrophy on neuroimaging was present in 13 of 32 patients. Pathological examination of the 10 brains from patients carrying expanded repeats revealed frontotemporal lobar degeneration with neuronal transactive response DNA binding protein-positive inclusions of variable type, size and morphology in all brains. Fluorescence in situ hybridization analysis of brain material from patients with the repeat expansion, a microtubule-associated protein tau or a progranulin mutation, and controls did not show RNA-positive inclusions specific for brains with the GGGGCC repeat expansion. The hexanucleotide repeat expansion in C9orf72 is an important cause of frontotemporal dementia with and without amyotrophic lateral sclerosis, and is sometimes associated with primary progressive aphasia. Neuropathological hallmarks include neuronal and glial inclusions, and dystrophic neurites containing transactive response DNA binding protein. Future studies are needed to explain the wide variation in clinical presentation.
Author Heutink, Peter
de Graaf, J. Roos A.
de Koning, Inge
van Schoor, Natasja M.
Dopper, Elise G. P.
Nicolaou, Nayia
Deeg, Dorly J. H.
Seelaar, Harro
Smits, Marion
Simón-Sánchez, Javier
Raaphorst, Joost
Pijnenburg, Yolande A. L.
van Swieten, John C.
van den Berg, Leonard H.
De Die-Smulders, Christine E. M.
Cohn-Hokke, Petra E.
Majoor-Krakauer, Danielle
Schelhaas, Helenius J.
Willemsen, Rob
Rozemuller, Annemieke J. M.
Hukema, Renate K.
Author_xml – sequence: 1
  givenname: Javier
  surname: Simón-Sánchez
  fullname: Simón-Sánchez, Javier
– sequence: 2
  givenname: Elise G. P.
  surname: Dopper
  fullname: Dopper, Elise G. P.
– sequence: 3
  givenname: Petra E.
  surname: Cohn-Hokke
  fullname: Cohn-Hokke, Petra E.
– sequence: 4
  givenname: Renate K.
  surname: Hukema
  fullname: Hukema, Renate K.
– sequence: 5
  givenname: Nayia
  surname: Nicolaou
  fullname: Nicolaou, Nayia
– sequence: 6
  givenname: Harro
  surname: Seelaar
  fullname: Seelaar, Harro
– sequence: 7
  givenname: J. Roos A.
  surname: de Graaf
  fullname: de Graaf, J. Roos A.
– sequence: 8
  givenname: Inge
  surname: de Koning
  fullname: de Koning, Inge
– sequence: 9
  givenname: Natasja M.
  surname: van Schoor
  fullname: van Schoor, Natasja M.
– sequence: 10
  givenname: Dorly J. H.
  surname: Deeg
  fullname: Deeg, Dorly J. H.
– sequence: 11
  givenname: Marion
  surname: Smits
  fullname: Smits, Marion
– sequence: 12
  givenname: Joost
  surname: Raaphorst
  fullname: Raaphorst, Joost
– sequence: 13
  givenname: Leonard H.
  surname: van den Berg
  fullname: van den Berg, Leonard H.
– sequence: 14
  givenname: Helenius J.
  surname: Schelhaas
  fullname: Schelhaas, Helenius J.
– sequence: 15
  givenname: Christine E. M.
  surname: De Die-Smulders
  fullname: De Die-Smulders, Christine E. M.
– sequence: 16
  givenname: Danielle
  surname: Majoor-Krakauer
  fullname: Majoor-Krakauer, Danielle
– sequence: 17
  givenname: Annemieke J. M.
  surname: Rozemuller
  fullname: Rozemuller, Annemieke J. M.
– sequence: 18
  givenname: Rob
  surname: Willemsen
  fullname: Willemsen, Rob
– sequence: 19
  givenname: Yolande A. L.
  surname: Pijnenburg
  fullname: Pijnenburg, Yolande A. L.
– sequence: 20
  givenname: Peter
  surname: Heutink
  fullname: Heutink, Peter
– sequence: 21
  givenname: John C.
  surname: van Swieten
  fullname: van Swieten, John C.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25589896$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22300876$$D View this record in MEDLINE/PubMed
BookMark eNp90c9rFDEUB_AgFbtdvXmWuYgeHJvfmzmWxapQKGg9h7eZFzcym4xJFtv_3rS7RRDx9CB83iN8v2fkJKaIhLxk9D2jgzjfZAjxHH5locQTsmBS054zpU_IglKqezMoekrOSvlBKZOC62fklHNBqVnpBfl6s8XOTSEGB1MHcexmqNs0pe8PD_MWY6p3M3bJd-vh-svlindbvIW4dxOmGkbsMs4ItcPbGWIJKZbn5KmHqeCL41ySb5cfbtaf-qvrj5_XF1e9k2pVe66Rcae8RIaGS800gpTGc4cjDu3vHhhw4JpKuvGCD-jNuDFCwUoaYCiW5M3h7pzTzz2WanehOJwmiJj2xQ5cDMoowZt8-1_ZcpGUC9Pmkrw60v1mh6Odc9hBvrOPkTXw-gigtIh8huhC-eOUMoMZ7h0_OJdTKRm9daFCbQHV1thkGbX3_dmH_uyhv7b07q-lx7v_5L8BEh2dnQ
CitedBy_id crossref_primary_10_1371_journal_pone_0056899
crossref_primary_10_1007_s00401_015_1476_2
crossref_primary_10_3389_fnmol_2014_00063
crossref_primary_10_1016_j_cortex_2021_09_005
crossref_primary_10_1007_s00401_012_1050_0
crossref_primary_10_1038_s41398_019_0381_1
crossref_primary_10_1016_j_nicl_2020_102300
crossref_primary_10_1016_j_neurobiolaging_2019_07_007
crossref_primary_10_1007_s00401_012_1029_x
crossref_primary_10_1534_genetics_115_179457
crossref_primary_10_1016_j_neurobiolaging_2019_10_017
crossref_primary_10_1212_01_wnl_0000436063_12890_b2
crossref_primary_10_1093_brain_awt030
crossref_primary_10_1111_ahg_12033
crossref_primary_10_1176_appi_neuropsych_16090168
crossref_primary_10_1007_s00415_021_10575_w
crossref_primary_10_3390_cells10020249
crossref_primary_10_1016_j_mcn_2012_12_006
crossref_primary_10_1016_j_neubiorev_2017_01_004
crossref_primary_10_1093_brain_awu248
crossref_primary_10_1016_S1474_4422_14_70233_9
crossref_primary_10_1002_ana_26677
crossref_primary_10_1016_j_neurobiolaging_2012_10_003
crossref_primary_10_1186_alzrt133
crossref_primary_10_1007_s00401_012_0970_z
crossref_primary_10_1007_s00401_013_1088_7
crossref_primary_10_1016_j_biopsych_2013_01_031
crossref_primary_10_1016_j_neurol_2013_07_010
crossref_primary_10_1186_s40478_015_0238_7
crossref_primary_10_1186_alzrt132
crossref_primary_10_7554_eLife_62718
crossref_primary_10_1007_s00401_014_1253_7
crossref_primary_10_1016_j_neurobiolaging_2017_12_015
crossref_primary_10_3390_jpm13091396
crossref_primary_10_1016_j_neurol_2013_07_014
crossref_primary_10_1186_alzrt136
crossref_primary_10_1002_mds_25838
crossref_primary_10_1007_s00401_017_1716_8
crossref_primary_10_15252_embr_201540607
crossref_primary_10_1038_nrneurol_2012_117
crossref_primary_10_1186_alzrt130
crossref_primary_10_1016_j_neurobiolaging_2019_02_006
crossref_primary_10_3233_JAD_160236
crossref_primary_10_1136_jnnp_2022_330152
crossref_primary_10_1002_alz_13551
crossref_primary_10_1101_cshperspect_a024133
crossref_primary_10_1038_s41467_022_33332_7
crossref_primary_10_1038_s41598_017_08857_3
crossref_primary_10_1080_13554794_2015_1080283
crossref_primary_10_1093_brain_awab410
crossref_primary_10_1093_hmg_ddt349
crossref_primary_10_1111_bpa_12354
crossref_primary_10_1097_WCO_0b013e32835a3efb
crossref_primary_10_3389_fnagi_2015_00171
crossref_primary_10_1002_mdc3_12677
crossref_primary_10_1016_j_cortex_2021_12_014
crossref_primary_10_1038_s41582_018_0009_8
crossref_primary_10_1136_bcr_2013_203458
crossref_primary_10_1590_0004_282X20140229
crossref_primary_10_3109_21678421_2016_1140786
crossref_primary_10_1007_s13311_015_0342_1
crossref_primary_10_1002_humu_22164
crossref_primary_10_1016_j_neurobiolaging_2013_07_016
crossref_primary_10_1101_cshperspect_a024224
crossref_primary_10_1016_j_neurobiolaging_2013_03_006
crossref_primary_10_3389_fnagi_2022_841711
crossref_primary_10_1016_j_neurobiolaging_2012_05_002
crossref_primary_10_1016_j_neubiorev_2016_03_033
crossref_primary_10_1016_j_neurol_2024_03_008
crossref_primary_10_1007_s11910_012_0268_5
crossref_primary_10_1111_nan_12845
crossref_primary_10_1590_S1980_57642013DN70100002
crossref_primary_10_1111_nan_12284
crossref_primary_10_1016_j_pneurobio_2022_102229
crossref_primary_10_1016_S1474_4422_13_70026_7
crossref_primary_10_1111_jnc_13654
crossref_primary_10_1007_s12264_020_00567_7
crossref_primary_10_1093_brain_aws357
crossref_primary_10_1093_hmg_ddu576
crossref_primary_10_3109_21678421_2014_959450
crossref_primary_10_1016_j_stemcr_2020_01_010
crossref_primary_10_3109_21678421_2013_765485
crossref_primary_10_1080_02687038_2014_911242
crossref_primary_10_1007_s00401_013_1125_6
crossref_primary_10_1212_WNL_0000000000010914
crossref_primary_10_1007_s00401_013_1149_y
crossref_primary_10_1016_S1474_4422_12_70043_1
crossref_primary_10_1111_ene_12211
crossref_primary_10_1016_j_tins_2013_04_010
crossref_primary_10_1016_j_gde_2017_02_008
crossref_primary_10_3109_17482968_2012_725415
crossref_primary_10_3109_21678421_2015_1111904
crossref_primary_10_3389_fgene_2018_00712
crossref_primary_10_1212_WNL_0b013e318268471a
crossref_primary_10_1093_brain_aws230
crossref_primary_10_3389_fneur_2022_861585
crossref_primary_10_1002_ajmg_b_32080
crossref_primary_10_1016_j_arr_2020_101172
crossref_primary_10_1016_j_parkreldis_2014_07_010
crossref_primary_10_1002_ana_25271
crossref_primary_10_3233_JAD_161142
crossref_primary_10_1016_j_neurol_2012_10_003
crossref_primary_10_3233_JAD_200795
crossref_primary_10_1016_j_jns_2013_09_013
crossref_primary_10_1016_j_nicl_2016_12_006
crossref_primary_10_1097_NRL_0000000000000147
crossref_primary_10_3233_JAD_150922
crossref_primary_10_1038_nrneurol_2014_159
crossref_primary_10_1016_j_neurobiolaging_2015_11_016
crossref_primary_10_1111_j_1440_1789_2012_01332_x
crossref_primary_10_3389_fneur_2020_550140
crossref_primary_10_1007_s00401_013_1181_y
crossref_primary_10_1016_j_neurol_2015_04_004
crossref_primary_10_1080_13554794_2014_951058
crossref_primary_10_1093_brain_aws144
crossref_primary_10_1186_s13024_022_00525_z
crossref_primary_10_1002_mds_25245
crossref_primary_10_1111_nan_12100
crossref_primary_10_2298_GENSR2301001M
crossref_primary_10_1007_s00401_014_1251_9
crossref_primary_10_1016_j_nicl_2013_06_005
crossref_primary_10_1101_cshperspect_a026757
crossref_primary_10_1080_15548627_2015_1121360
crossref_primary_10_1021_acs_biochem_4c00308
crossref_primary_10_1007_s00401_014_1365_0
crossref_primary_10_1016_j_celrep_2020_108538
crossref_primary_10_1007_s00401_019_02070_4
crossref_primary_10_1016_j_neurobiolaging_2020_08_018
crossref_primary_10_1007_s00401_013_1200_z
crossref_primary_10_1007_s12035_013_8528_1
crossref_primary_10_1007_s00401_014_1380_1
crossref_primary_10_1007_s11910_015_0582_9
crossref_primary_10_2298_GENSR2203313M
crossref_primary_10_1002_ana_24469
crossref_primary_10_1080_10408363_2022_2150833
crossref_primary_10_1007_s11682_020_00429_w
crossref_primary_10_1016_j_neurobiolaging_2012_06_008
crossref_primary_10_1212_WNL_0b013e3182a8250c
crossref_primary_10_1007_s00415_014_7456_y
crossref_primary_10_1002_acn3_50875
crossref_primary_10_1007_s00401_015_1473_5
crossref_primary_10_1002_humu_22244
crossref_primary_10_1186_alzrt148
crossref_primary_10_1590_1980_57642015DN94000413
crossref_primary_10_1038_nrneurol_2012_58
crossref_primary_10_1186_alzrt149
crossref_primary_10_1007_s11910_015_0567_8
crossref_primary_10_1007_s10048_024_00766_8
crossref_primary_10_1186_s40478_024_01911_y
crossref_primary_10_1111_cge_12117
crossref_primary_10_3389_fnins_2019_00486
crossref_primary_10_1186_alzrt141
crossref_primary_10_3233_JAD_170913
crossref_primary_10_1007_s00401_013_1237_z
crossref_primary_10_1017_cjn_2023_248
crossref_primary_10_1038_mp_2015_159
crossref_primary_10_1093_brain_awz078
crossref_primary_10_1093_bioinformatics_bts725
crossref_primary_10_1111_nyas_12638
crossref_primary_10_1515_revneuro_2023_0060
crossref_primary_10_1016_j_expneurol_2014_05_020
crossref_primary_10_1016_j_neurobiolaging_2013_11_033
crossref_primary_10_1038_s41419_017_0022_7
crossref_primary_10_3390_cells11132066
crossref_primary_10_1007_s00401_012_1048_7
crossref_primary_10_1016_j_neurobiolaging_2013_09_037
crossref_primary_10_1016_j_yneu_2012_05_040
crossref_primary_10_1212_WNL_0000000000004393
crossref_primary_10_3389_fncel_2017_00126
crossref_primary_10_1007_s00401_013_1232_4
crossref_primary_10_1016_j_jalz_2013_09_013
crossref_primary_10_1073_pnas_1219643110
crossref_primary_10_1371_journal_pone_0208383
crossref_primary_10_1016_j_neurobiolaging_2015_07_004
crossref_primary_10_1097_NEN_0000000000000182
crossref_primary_10_3389_fgene_2022_959258
crossref_primary_10_1016_j_bandl_2013_02_004
crossref_primary_10_1016_j_neuron_2013_07_033
crossref_primary_10_1111_ene_12894
crossref_primary_10_1080_13554794_2012_732090
crossref_primary_10_3109_21678421_2013_838586
crossref_primary_10_1007_s00401_014_1286_y
Cites_doi 10.1016/j.jns.2010.07.004
10.1111/j.1440-1789.2010.01171.x
10.1126/science.1166066
10.1212/WNL.59.7.1077
10.1212/WNL.51.6.1546
10.1111/j.1750-3639.2007.00052.x
10.1016/0022-510X(94)90191-0
10.1212/WNL.0b013e3181df0a1b
10.1212/01.wnl.0000200048.53766.b4
10.1093/jnen/63.8.801
10.1038/nature05016
10.1016/j.bbadis.2006.01.004
10.1038/ng.442
10.1212/01.wnl.0000187068.92184.63
10.1016/S1474-4422(10)70184-8
10.1136/jnnp.2010.212225
10.1007/s00415-010-5815-x
10.2353/ajpath.2007.070182
10.1007/s00401-011-0845-8
10.1038/ng.536
10.1126/science.1165942
10.1016/j.neuron.2011.09.011
10.1016/j.jocn.2009.05.005
10.1126/science.1154584
10.1212/WNL.0b013e31821103e6
10.1001/archneurol.2010.146
10.1126/science.1134108
10.1007/s00401-008-0402-2
10.1002/ana.21948
10.1212/WNL.0b013e3181a55f1c
10.1212/WNL.58.12.1791
10.1016/j.ajhg.2011.05.015
10.1212/WNL.0b013e31821d767b
10.1212/WNL.44.10.1872
10.1212/WNL.0b013e318202038c
10.1038/31508
10.1136/jnnp.74.11.1516
10.1016/j.neuron.2011.09.010
10.1093/brain/awl030
10.1038/nature08971
10.1038/nature05017
10.1016/j.neuron.2010.11.036
10.1056/NEJM200105313442207
10.1136/jmg.33.12.1022
10.1212/WNL.58.11.1615
10.1093/brain/awm024
10.1007/s00401-007-0285-7
10.1038/364362c0
10.1093/brain/awp248
10.1212/01.wnl.0000319702.37497.72
10.1093/hmg/ddr299
10.1001/archneur.64.2.240
10.1136/jnnp.2009.204081
ContentType Journal Article
Copyright 2015 INIST-CNRS
Copyright_xml – notice: 2015 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7X8
DOI 10.1093/brain/awr353
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList Neurosciences Abstracts
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1460-2156
EndPage 735
ExternalDocumentID 22300876
25589896
10_1093_brain_awr353
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-E4
-~X
.2P
.55
.GJ
.I3
.XZ
.ZR
0R~
1CY
1TH
23N
2WC
354
3O-
4.4
41~
482
48X
53G
5GY
5RE
5VS
5WA
5WD
6PF
70D
AABZA
AACZT
AAGKA
AAIMJ
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAVLN
AAWDT
AAWTL
AAYJJ
AAYXX
ABDFA
ABDPE
ABEJV
ABEUO
ABGNP
ABIME
ABIVO
ABIXL
ABJNI
ABKDP
ABLJU
ABMNT
ABNGD
ABNHQ
ABNKS
ABPIB
ABPQP
ABPTD
ABQLI
ABQNK
ABSMQ
ABVGC
ABWST
ABXVV
ABXZS
ABZBJ
ABZEO
ACBNA
ACFRR
ACGFS
ACIWK
ACPQN
ACPRK
ACUFI
ACUKT
ACUTJ
ACUTO
ACVCV
ACYHN
ACZBC
ADBBV
ADEYI
ADEZT
ADGKP
ADGZP
ADHKW
ADHZD
ADIPN
ADMTO
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEHUL
AEJOX
AEKPW
AEKSI
AELWJ
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFQV
AFFZL
AFGWE
AFIYH
AFOFC
AFSHK
AFXAL
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGORE
AGQPQ
AGQXC
AGSYK
AGUTN
AHGBF
AHMBA
AHMMS
AHXPO
AI.
AIJHB
AJBYB
AJDVS
AJEEA
AJNCP
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
ANFBD
APIBT
APJGH
APWMN
AQDSO
AQKUS
ARIXL
ASAOO
ASPBG
ATDFG
ATGXG
ATTQO
AVNTJ
AVWKF
AXUDD
AYOIW
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BQDIO
BR6
BSWAC
BTRTY
BVRKM
BZKNY
C1A
C45
CAG
CDBKE
CITATION
COF
CS3
CXTWN
CZ4
DAKXR
DFGAJ
DIK
DILTD
DU5
D~K
E3Z
EBS
EE~
EIHJH
EJD
ELUNK
EMOBN
ENERS
F5P
F9B
FECEO
FEDTE
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
IOX
J21
J5H
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
MBLQV
MBTAY
MHKGH
ML0
MVM
N4W
N9A
NGC
NLBLG
NOMLY
NOYVH
NTWIH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OBFPC
OBOKY
OCZFY
ODMLO
OHH
OHT
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RIG
RNI
ROL
ROX
ROZ
RUSNO
RW1
RXO
RZF
RZO
TCN
TCURE
TEORI
TJX
TLC
TMA
TR2
VH1
VVN
W8F
WH7
WOQ
X7H
X7M
XJT
XOL
YAYTL
YKOAZ
YQJ
YSK
YXANX
ZCG
ZGI
ZKB
ZKX
ZXP
~91
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7X8
ID FETCH-LOGICAL-c457t-26e12c5f4e1e824616ea448f2cede9000fa1a2a26040bf329ef8db835a748a1e3
ISSN 0006-8950
1460-2156
IngestDate Thu Jul 10 22:44:51 EDT 2025
Thu Jul 10 18:18:40 EDT 2025
Mon Jul 21 05:58:38 EDT 2025
Mon Jul 21 09:17:56 EDT 2025
Tue Jul 01 00:46:04 EDT 2025
Thu Apr 24 23:08:56 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Nervous system diseases
Phenotype
Central nervous system disease
Amyotrophic lateral sclerosis
Degenerative disease
Degeneration
Frontotemporal dementia
Spinal cord disease
C9orf72 repeat expansion
frontotemporal lobar degeneration
Cerebral disorder
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c457t-26e12c5f4e1e824616ea448f2cede9000fa1a2a26040bf329ef8db835a748a1e3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://academic.oup.com/brain/article-pdf/135/3/723/17347039/awr353.pdf
PMID 22300876
PQID 1434023814
PQPubID 23462
PageCount 13
ParticipantIDs proquest_miscellaneous_923958532
proquest_miscellaneous_1434023814
pubmed_primary_22300876
pascalfrancis_primary_25589896
crossref_citationtrail_10_1093_brain_awr353
crossref_primary_10_1093_brain_awr353
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-03-01
PublicationDateYYYYMMDD 2012-03-01
PublicationDate_xml – month: 03
  year: 2012
  text: 2012-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: England
PublicationTitle Brain (London, England : 1878)
PublicationTitleAlternate Brain
PublicationYear 2012
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Johnson ( key 20170522091325_awr353-B16) 2010; 68
Seelaar ( key 20170522091325_awr353-B42) 2007; 130
Dejesus-Hernandez ( key 20170522091325_awr353-B8) 2011; 72
Thal ( key 20170522091325_awr353-B44) 2002; 58
Maruyama ( key 20170522091325_awr353-B28) 2010; 465
Baker ( key 20170522091325_awr353-B1) 2006; 442
Warner ( key 20170522091325_awr353-B52) 1996; 33
Lillo ( key 20170522091325_awr353-B24) 2010; 67
Rowland ( key 20170522091325_awr353-B39) 2001; 344
Sreedharan ( key 20170522091325_awr353-B43) 2008; 319
van Swieten ( key 20170522091325_awr353-B49) 2007; 17
Renton ( key 20170522091325_awr353-B36) 2011
Hiji ( key 20170522091325_awr353-B13) 2008; 116
Majoor-Krakauer ( key 20170522091325_awr353-B27) 1994; 44
Kim ( key 20170522091325_awr353-B17) 2009; 16
Vance ( key 20170522091325_awr353-B51) 2009; 323
Coon ( key 20170522091325_awr353-B6) 2011; 76
Gorno-Tempini ( key 20170522091325_awr353-B11) 2011; 76
Brooks ( key 20170522091325_awr353-B4) 1994; 124
Goldman ( key 20170522091325_awr353-B10) 2005; 65
Vance ( key 20170522091325_awr353-B50) 2006; 129
Gros-Louis ( key 20170522091325_awr353-B12) 2006; 1762
Polvikoski ( key 20170522091325_awr353-B34) 2003; 74
Laaksovirta ( key 20170522091325_awr353-B22) 2010; 9
Hodges ( key 20170522091325_awr353-B14) 2010; 133
Hutton ( key 20170522091325_awr353-B15) 1998; 393
Kwiatkowski ( key 20170522091325_awr353-B21) 2009; 323
Morita ( key 20170522091325_awr353-B30) 2006; 66
Pearson ( key 20170522091325_awr353-B33) 2011; 258
Todd ( key 20170522091325_awr353-B45) 2010; 67
Zhang ( key 20170522091325_awr353-B54) 2008; 115
Rosen ( key 20170522091325_awr353-B38) 1993; 364
Le Ber ( key 20170522091325_awr353-B23) 2009; 72
Neumann ( key 20170522091325_awr353-B32) 2006; 314
Neary ( key 20170522091325_awr353-B31) 1998; 51
Cairns ( key 20170522091325_awr353-B5) 2007; 171
Valdmanis ( key 20170522091325_awr353-B46) 2007; 64
Boxer ( key 20170522091325_awr353-B3) 2011; 82
Seelaar ( key 20170522091325_awr353-B41) 2011; 82
Van Deerlin ( key 20170522091325_awr353-B47) 2010; 42
Lomen-Hoerth ( key 20170522091325_awr353-B25) 2002; 59
Mok ( key 20170522091325_awr353-B29) 2011; 33
Cruts ( key 20170522091325_awr353-B7) 2006; 442
Seelaar ( key 20170522091325_awr353-B40) 2008; 71
King ( key 20170522091325_awr353-B18) 2011; 31
Wojciechowska ( key 20170522091325_awr353-B53) 2011; 20
Kobayashi ( key 20170522091325_awr353-B19) 2011; 89
Ratnavalli ( key 20170522091325_awr353-B35) 2002; 58
Rohrer ( key 20170522091325_awr353-B37) 2010; 75
Mackenzie ( key 20170522091325_awr353-B26) 2011; 122
Kuwahara ( key 20170522091325_awr353-B20) 2010; 297
Bigio ( key 20170522091325_awr353-B2) 2004; 63
van Es ( key 20170522091325_awr353-B48) 2009; 41
Gliebus ( key 20170522091325_awr353-B9) 2010; 74
References_xml – volume: 297
  start-page: 92
  year: 2010
  ident: key 20170522091325_awr353-B20
  article-title: Frontotemporal lobar degeneration with motor neuron disease showing severe and circumscribed atrophy of anterior temporal lobes
  publication-title: J Neurol Sci
  doi: 10.1016/j.jns.2010.07.004
– volume: 31
  start-page: 239
  year: 2011
  ident: key 20170522091325_awr353-B18
  article-title: Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43
  publication-title: Neuropathology
  doi: 10.1111/j.1440-1789.2010.01171.x
– volume: 323
  start-page: 1205
  year: 2009
  ident: key 20170522091325_awr353-B21
  article-title: Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis
  publication-title: Science
  doi: 10.1126/science.1166066
– volume: 59
  start-page: 1077
  year: 2002
  ident: key 20170522091325_awr353-B25
  article-title: The overlap of amyotrophic lateral sclerosis and frontotemporal dementia
  publication-title: Neurology
  doi: 10.1212/WNL.59.7.1077
– volume: 51
  start-page: 1546
  year: 1998
  ident: key 20170522091325_awr353-B31
  article-title: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria
  publication-title: Neurology
  doi: 10.1212/WNL.51.6.1546
– volume: 17
  start-page: 63
  year: 2007
  ident: key 20170522091325_awr353-B49
  article-title: Hereditary frontotemporal dementia caused by Tau gene mutations
  publication-title: Brain Pathol
  doi: 10.1111/j.1750-3639.2007.00052.x
– volume: 124
  start-page: 96
  year: 1994
  ident: key 20170522091325_awr353-B4
  article-title: El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors
  publication-title: J Neurol Sci
  doi: 10.1016/0022-510X(94)90191-0
– volume: 74
  start-page: 1607
  year: 2010
  ident: key 20170522091325_awr353-B9
  article-title: Asymmetric TDP-43 distribution in primary progressive aphasia with progranulin mutation
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e3181df0a1b
– volume: 66
  start-page: 839
  year: 2006
  ident: key 20170522091325_awr353-B30
  article-title: A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000200048.53766.b4
– volume: 63
  start-page: 801
  year: 2004
  ident: key 20170522091325_awr353-B2
  article-title: Neuronal ubiquitinated intranuclear inclusions in familial and non-familial frontotemporal dementia of the motor neuron disease type associated with amyotrophic lateral sclerosis
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1093/jnen/63.8.801
– volume: 442
  start-page: 916
  year: 2006
  ident: key 20170522091325_awr353-B1
  article-title: Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
  publication-title: Nature
  doi: 10.1038/nature05016
– volume: 1762
  start-page: 956
  year: 2006
  ident: key 20170522091325_awr353-B12
  article-title: Genetics of familial and sporadic amyotrophic lateral sclerosis
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbadis.2006.01.004
– volume: 41
  start-page: 1083
  year: 2009
  ident: key 20170522091325_awr353-B48
  article-title: Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis
  publication-title: Nat Genet
  doi: 10.1038/ng.442
– volume: 65
  start-page: 1817
  year: 2005
  ident: key 20170522091325_awr353-B10
  article-title: Comparison of family histories in FTLD subtypes and related tauopathies
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000187068.92184.63
– volume: 9
  start-page: 978
  year: 2010
  ident: key 20170522091325_awr353-B22
  article-title: Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(10)70184-8
– volume: 82
  start-page: 476
  year: 2011
  ident: key 20170522091325_awr353-B41
  article-title: Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.2010.212225
– volume: 258
  start-page: 647
  year: 2011
  ident: key 20170522091325_awr353-B33
  article-title: Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p
  publication-title: J Neurol
  doi: 10.1007/s00415-010-5815-x
– volume: 171
  start-page: 227
  year: 2007
  ident: key 20170522091325_awr353-B5
  article-title: TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2007.070182
– volume: 122
  start-page: 111
  year: 2011
  ident: key 20170522091325_awr353-B26
  article-title: A harmonized classification system for FTLD-TDP pathology
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-011-0845-8
– volume: 42
  start-page: 234
  year: 2010
  ident: key 20170522091325_awr353-B47
  article-title: Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions
  publication-title: Nat Genet
  doi: 10.1038/ng.536
– volume: 323
  start-page: 1208
  year: 2009
  ident: key 20170522091325_awr353-B51
  article-title: Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6
  publication-title: Science
  doi: 10.1126/science.1165942
– volume: 72
  start-page: 245
  year: 2011
  ident: key 20170522091325_awr353-B8
  article-title: Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS
  publication-title: Neuron
  doi: 10.1016/j.neuron.2011.09.011
– volume: 16
  start-page: 1683
  year: 2009
  ident: key 20170522091325_awr353-B17
  article-title: Semantic dementia combined with motor neuron disease
  publication-title: J Clin Neurosci
  doi: 10.1016/j.jocn.2009.05.005
– volume: 319
  start-page: 1668
  year: 2008
  ident: key 20170522091325_awr353-B43
  article-title: TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis
  publication-title: Science
  doi: 10.1126/science.1154584
– volume: 76
  start-page: 1006
  year: 2011
  ident: key 20170522091325_awr353-B11
  article-title: Classification of primary progressive aphasia and its variants
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e31821103e6
– volume: 67
  start-page: 826
  year: 2010
  ident: key 20170522091325_awr353-B24
  article-title: Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis
  publication-title: Arch Neurol
  doi: 10.1001/archneurol.2010.146
– volume: 314
  start-page: 130
  year: 2006
  ident: key 20170522091325_awr353-B32
  article-title: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
  publication-title: Science
  doi: 10.1126/science.1134108
– volume: 116
  start-page: 183
  year: 2008
  ident: key 20170522091325_awr353-B13
  article-title: White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-008-0402-2
– volume: 67
  start-page: 291
  year: 2010
  ident: key 20170522091325_awr353-B45
  article-title: RNA-mediated neurodegeneration in repeat expansion disorders
  publication-title: Ann Neurol
  doi: 10.1002/ana.21948
– volume: 72
  start-page: 1669
  year: 2009
  ident: key 20170522091325_awr353-B23
  article-title: Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e3181a55f1c
– volume: 58
  start-page: 1791
  year: 2002
  ident: key 20170522091325_awr353-B44
  article-title: Phases of A beta-deposition in the human brain and its relevance for the development of AD
  publication-title: Neurology
  doi: 10.1212/WNL.58.12.1791
– volume: 89
  start-page: 121
  year: 2011
  ident: key 20170522091325_awr353-B19
  article-title: Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement
  publication-title: Am J Hum Genet
  doi: 10.1016/j.ajhg.2011.05.015
– volume: 76
  start-page: 1886
  year: 2011
  ident: key 20170522091325_awr353-B6
  article-title: Predicting survival in frontotemporal dementia with motor neuron disease
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e31821d767b
– volume: 44
  start-page: 1872
  year: 1994
  ident: key 20170522091325_awr353-B27
  article-title: Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility
  publication-title: Neurology
  doi: 10.1212/WNL.44.10.1872
– volume: 75
  start-page: 2204
  year: 2010
  ident: key 20170522091325_awr353-B37
  article-title: TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e318202038c
– volume: 393
  start-page: 702
  year: 1998
  ident: key 20170522091325_awr353-B15
  article-title: Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
  publication-title: Nature
  doi: 10.1038/31508
– volume: 33
  start-page: 209
  year: 2011
  ident: key 20170522091325_awr353-B29
  article-title: The chromosome 9 ALS and FTD locus is probably derived from a single founder
  publication-title: Neurobiol Aging
– volume: 74
  start-page: 1516
  year: 2003
  ident: key 20170522091325_awr353-B34
  article-title: Familial motor neurone disease with dementia: phenotypic variation and cerebellar pathology
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.74.11.1516
– year: 2011
  ident: key 20170522091325_awr353-B36
  article-title: A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD
  publication-title: Neuron
  doi: 10.1016/j.neuron.2011.09.010
– volume: 129
  start-page: 868
  year: 2006
  ident: key 20170522091325_awr353-B50
  article-title: Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3
  publication-title: Brain
  doi: 10.1093/brain/awl030
– volume: 465
  start-page: 223
  year: 2010
  ident: key 20170522091325_awr353-B28
  article-title: Mutations of optineurin in amyotrophic lateral sclerosis
  publication-title: Nature
  doi: 10.1038/nature08971
– volume: 442
  start-page: 920
  year: 2006
  ident: key 20170522091325_awr353-B7
  article-title: Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21
  publication-title: Nature
  doi: 10.1038/nature05017
– volume: 68
  start-page: 857
  year: 2010
  ident: key 20170522091325_awr353-B16
  article-title: Exome sequencing reveals VCP mutations as a cause of familial ALS
  publication-title: Neuron
  doi: 10.1016/j.neuron.2010.11.036
– volume: 344
  start-page: 1688
  year: 2001
  ident: key 20170522091325_awr353-B39
  article-title: Amyotrophic lateral sclerosis
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200105313442207
– volume: 33
  start-page: 1022
  year: 1996
  ident: key 20170522091325_awr353-B52
  article-title: A general method for the detection of large CAG repeat expansions by fluorescent PCR
  publication-title: J Med Genet
  doi: 10.1136/jmg.33.12.1022
– volume: 58
  start-page: 1615
  year: 2002
  ident: key 20170522091325_awr353-B35
  article-title: The prevalence of frontotemporal dementia
  publication-title: Neurology
  doi: 10.1212/WNL.58.11.1615
– volume: 130
  start-page: 1375
  year: 2007
  ident: key 20170522091325_awr353-B42
  article-title: TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without progranulin mutations
  publication-title: Brain
  doi: 10.1093/brain/awm024
– volume: 115
  start-page: 115
  year: 2008
  ident: key 20170522091325_awr353-B54
  article-title: TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-007-0285-7
– volume: 364
  start-page: 362
  year: 1993
  ident: key 20170522091325_awr353-B38
  article-title: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
  publication-title: Nature
  doi: 10.1038/364362c0
– volume: 133
  start-page: 300
  year: 2010
  ident: key 20170522091325_awr353-B14
  article-title: Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases
  publication-title: Brain
  doi: 10.1093/brain/awp248
– volume: 71
  start-page: 1220
  year: 2008
  ident: key 20170522091325_awr353-B40
  article-title: Distinct genetic forms of frontotemporal dementia
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000319702.37497.72
– volume: 20
  start-page: 3811
  year: 2011
  ident: key 20170522091325_awr353-B53
  article-title: Cellular toxicity of expanded RNA repeats: focus on RNA foci
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddr299
– volume: 64
  start-page: 240
  year: 2007
  ident: key 20170522091325_awr353-B46
  article-title: Three families with amyotrophic lateral sclerosis and frontotemporal dementia with evidence of linkage to chromosome 9p
  publication-title: Arch Neurol
  doi: 10.1001/archneur.64.2.240
– volume: 82
  start-page: 196
  year: 2011
  ident: key 20170522091325_awr353-B3
  article-title: Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.2009.204081
SSID ssj0014326
Score 2.5121245
Snippet There is increasing evidence that frontotemporal dementia and amyotrophic lateral sclerosis are part of a disease continuum. Recently, a hexanucleotide repeat...
SourceID proquest
pubmed
pascalfrancis
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 723
SubjectTerms Adult
Age of Onset
Aged
Aged, 80 and over
Amyotrophic Lateral Sclerosis - genetics
Amyotrophic Lateral Sclerosis - pathology
Amyotrophic Lateral Sclerosis - psychology
Autopsy
Biological and medical sciences
C9orf72 Protein
Cohort Studies
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
DNA Repeat Expansion
DNA-Binding Proteins - genetics
Female
Frontotemporal Dementia - genetics
Frontotemporal Dementia - pathology
Frontotemporal Dementia - psychology
Genotype
Humans
Immunohistochemistry
In Situ Hybridization
Intercellular Signaling Peptides and Proteins - genetics
Male
Medical sciences
Middle Aged
Netherlands
Neurology
Neurons - pathology
Neuropsychological Tests
Pedigree
Polymerase Chain Reaction
Proteins - genetics
tau Proteins - genetics
Tissue Banks
Title The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions
URI https://www.ncbi.nlm.nih.gov/pubmed/22300876
https://www.proquest.com/docview/1434023814
https://www.proquest.com/docview/923958532
Volume 135
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9NAEF_qCSKI-G39OFbQp5K7yybdJI8qliKcir2DvpXNZoLlrkloUzzu3f_bmd1N0uAV1JdQkm0XZn6d_GZ2Phh7G0tNBR_SQy6uvXAMsRdLJT0fEoKXr7SgeufTL3J6Hn6ej-eDwa-drKVtnR7p6xvrSv5Hq3gP9UpVsv-g2fZH8QZ-Rv3iFTWM17_WcVvaaCr-Vd1ZM8reKk2IlVIukq_fJ5FAYnilCuphXNbLjEamVBQigCs0Cps2dNc2PFLL4saZHzaQEEfxTiBhtlzRqfuHoPBm5vjdLxAQ1zYVl96-LWcuq8pV2VwuqfP1aGfq8Y_Cm5YXNmOIpn2prlRiur2AleO6BVJkF6F1IQvK_Whyto7AmtlQnnhINmTPDtu-JQ5w3-pRsGNYI1uV_IfBt82w0rUJo0zUz3Uw7i1EcVQro37kQab_Xvfia9MRm0e32G0RIQWjmvF5mymEjFJIVzOB2x2bzY7tVtRL2n25R2zuVWqDms7tcJT93othMWcP2H3nfvD3FksP2QCKR-zOqUuweMxmCCneQIqjpvkupHgLKV7m3EGK9yHFLaR4B6kn7Hzy6ezj1HNzNzwdjqPaExJ8ocd5CD7E1G9QgkIvPhcaMqAhs7nylVDoCYcnaR6IBPI4S5HKqyiMlQ_BU3ZQlAU8Z9wHyIM0y7IAIBRRlMQqyn0tdaLjTEg9ZKNGaAvtmtLTbJTLhU2OCBZG2gsr7SF7166ubDOWPesOe_JvF6P_TONS5ZC9aRSyQHNKZ2SqgHK7QU84CA2NDYeM71mDPlGCXnYghuyZVWa3gQPDi71PXrK73V_iFTuo11t4jby2Tg8N6n4DGl-iBw
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+clinical+and+pathological+phenotype+of+C9ORF72+hexanucleotide+repeat+expansions&rft.jtitle=Brain+%28London%2C+England+%3A+1878%29&rft.au=Sim%C3%B3n-S%C3%A1nchez%2C+Javier&rft.au=Dopper%2C+Elise+G+P&rft.au=Cohn-Hokke%2C+Petra+E&rft.au=Hukema%2C+Renate+K&rft.date=2012-03-01&rft.eissn=1460-2156&rft.volume=135&rft.issue=Pt+3&rft.spage=723&rft_id=info:doi/10.1093%2Fbrain%2Fawr353&rft_id=info%3Apmid%2F22300876&rft.externalDocID=22300876
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-8950&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-8950&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-8950&client=summon